GLOBAL RESEARCH ARCHIVE
OSEBX weekly valuation monitor
Research evidence excerpt
OSEBX weekly valuation monitor
Gjensidige Forsikring
BUY, Target price NOK 300, Share price NOK 249 Financials, MCAP NOK 124,400m
Are you not entertained?
Unwarranted sell-off amid overstated fears of AI-disruption, Danish WC ruling and regulatory scrutiny
• AI fears regarding distribution model and autonomous vehicles are overdone;
• Business- and distribution model fears: Market underestimate the uniqueness of the Nordic market and consumer needs.
• Autonomous vehicles: AVs are likely inflationary on claims (and premiums), and highly unlikely to make car insurance obsolete.
• Danish SC ruling on workers comp. (WC) weighs on sentiment, but we think the outcome can be net-positive to the insurers.
• We consider concerns of Norwegian authorities interfering due to temporary strong profitability highly speculative.
Significant earnings momentum, with upside risk to both short-term and longer-term estimates
• Strong premium growth momentum, operational improvements, scale and cost initiatives to drive earnings +10% p.a. in ’26e-’28e.
• Q2 seems to be another highly benign insurance quarter and the investment result is set to rebound after a muted Q1.
• Premium growth expectations of 4-5% for ’27e-’28e likely too conservative; potential 8-12% upside risk to ’27e-28e EPS.
35% TSR potential next 12 months; unmatched risk/reward across our Norwegian Financials coverage
• Ripe for a re-rating; ’27e-’28e P/E 14x-13x, 20-25% discount to 10Y avg. P/E.
• 7-8% dividend yield amid a strong solvency position despite a temporary hit from the Danish WC reserves strengthening.
• A ’27e EPS of NOK 19 scenario is not unrealistic – applying a P/E 17.5x gives NOK 317 + NOK 16 in DPS; 12m TSR of 35%.
The English excerpt is extracted automatically from the cited source page and may contain layout or recognition errors. It is never batch translated.
Open report viewer